Will AI revolutionize drug development? Researchers explain why it depends on how it’s used

Medical Xpress January 6, 2025
Duxin Sun and Christian Macedonia, The Conversation

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public.

“Artificial intelligence is taking over drug development,” claim some companies and researchers. Over the past few years, interest in using AI to design drugs and optimize clinical trials has driven a surge in research and investment. AI-driven platforms like AlphaFold, which won the 2024 Nobel Prize for its ability to predict the structure of proteins and design new ones, showcase AI’s potential to accelerate drug development.

AI in drug discovery is “nonsense,” warn some industry veterans. They urge that “AI’s potential to accelerate drug discovery needs a reality check,” as AI-generated drugs have yet to demonstrate...

Today's Sponsors

Today's Sponsor